TR200302001T4 - ''Oktahidro-2H-pirido[1,2-a] pirazin türevleri, bunların hazırlanma yöntemleri ve bunları içeren farmasötik bileşimler'' - Google Patents

''Oktahidro-2H-pirido[1,2-a] pirazin türevleri, bunların hazırlanma yöntemleri ve bunları içeren farmasötik bileşimler''

Info

Publication number
TR200302001T4
TR200302001T4 TR2003/02001T TR200302001T TR200302001T4 TR 200302001 T4 TR200302001 T4 TR 200302001T4 TR 2003/02001 T TR2003/02001 T TR 2003/02001T TR 200302001 T TR200302001 T TR 200302001T TR 200302001 T4 TR200302001 T4 TR 200302001T4
Authority
TR
Turkey
Prior art keywords
pyrido
preparation
methods
pharmaceutical compositions
compositions containing
Prior art date
Application number
TR2003/02001T
Other languages
English (en)
Turkish (tr)
Inventor
Goldstein Solo
Poissonnet Guillaume
Parmentier Jean-Gilles
Lestage Pierre
Lockhart Brian
Original Assignee
Les Labora Tories Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Labora Tories Servier filed Critical Les Labora Tories Servier
Publication of TR200302001T4 publication Critical patent/TR200302001T4/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TR2003/02001T 2001-07-12 2002-07-11 ''Oktahidro-2H-pirido[1,2-a] pirazin türevleri, bunların hazırlanma yöntemleri ve bunları içeren farmasötik bileşimler'' TR200302001T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0109260A FR2827288B1 (fr) 2001-07-12 2001-07-12 Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
TR200302001T4 true TR200302001T4 (tr) 2004-01-21

Family

ID=8865405

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2003/02001T TR200302001T4 (tr) 2001-07-12 2002-07-11 ''Oktahidro-2H-pirido[1,2-a] pirazin türevleri, bunların hazırlanma yöntemleri ve bunları içeren farmasötik bileşimler''

Country Status (24)

Country Link
US (1) US6992085B2 (enExample)
EP (1) EP1275647B1 (enExample)
JP (1) JP3950018B2 (enExample)
KR (1) KR100485020B1 (enExample)
CN (1) CN1197863C (enExample)
AR (1) AR036166A1 (enExample)
AT (1) ATE254124T1 (enExample)
AU (1) AU2002300094B2 (enExample)
BR (1) BR0202681A (enExample)
CA (1) CA2394027C (enExample)
DE (1) DE60200089T2 (enExample)
DK (1) DK1275647T3 (enExample)
EA (1) EA005160B1 (enExample)
ES (1) ES2210219T3 (enExample)
FR (1) FR2827288B1 (enExample)
HU (1) HUP0202282A3 (enExample)
MX (1) MXPA02006699A (enExample)
NO (1) NO322966B1 (enExample)
NZ (1) NZ520120A (enExample)
PL (1) PL355034A1 (enExample)
PT (1) PT1275647E (enExample)
SI (1) SI1275647T1 (enExample)
TR (1) TR200302001T4 (enExample)
ZA (1) ZA200205596B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1611902A4 (en) * 2003-04-03 2006-04-12 Kyowa Hakko Kogyo Kk MEANS FOR THE PREVENTION AND / OR TREATMENT OF NEUROPATHIC PAIN
MY141255A (en) * 2003-12-11 2010-03-31 Memory Pharm Corp Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
FR2866647B1 (fr) * 2004-02-20 2006-10-27 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BRPI0512567A (pt) * 2004-06-22 2008-03-25 Pfizer Prod Inc compostos antagonistas de receptor de histamina-3 diazabicìclico e respectivas composições farmacêuticas
RU2442775C2 (ru) * 2005-07-04 2012-02-20 Хай Пойнт Фармасьютикалс, ЛЛС Антагонисты гистаминовых н3-рецепторов
EP2386554A1 (en) * 2005-07-04 2011-11-16 High Point Pharmaceuticals, LLC Compounds active at the histamine H3 receptor
JP2009531314A (ja) * 2006-03-10 2009-09-03 ニューロジェン・コーポレーション ピペラジニルオキソアルキルテトラヒドロイソキノリン類および関連類似物
KR100871691B1 (ko) 2006-10-16 2008-12-05 삼성전자주식회사 병렬 비트 테스트 방법 및 그 방법을 사용하는 반도체메모리 장치
WO2018021447A1 (ja) 2016-07-28 2018-02-01 塩野義製薬株式会社 ドーパミンd3受容体拮抗作用を有する含窒素縮環化合物
BR112020014875A2 (pt) 2018-01-26 2020-12-08 Shionogi & Co., Ltd. Composto cíclico condensado tendo antagonismo de receptor de dopamina d3

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes
GB8518236D0 (en) * 1985-07-19 1985-08-29 Beecham Group Plc Compounds
WO1994006794A1 (en) * 1992-09-24 1994-03-31 National Institutes Of Health Aralkyl diazabicycloalkane derivatives for cns disorders
US5731307A (en) * 1994-09-30 1998-03-24 Pfizer, Inc. Neuroleptic 2,7-disubtituted perhydro-1h-pyrido 1, 2-A!pyrazines
US6231833B1 (en) * 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
WO2001005772A1 (en) * 1999-07-19 2001-01-25 Merck Frosst Canada & Co. Pyrazinones, compositions containing such compounds

Also Published As

Publication number Publication date
CN1397557A (zh) 2003-02-19
ES2210219T3 (es) 2004-07-01
DE60200089D1 (de) 2003-12-18
PT1275647E (pt) 2004-03-31
EP1275647A1 (fr) 2003-01-15
US20030195216A1 (en) 2003-10-16
AR036166A1 (es) 2004-08-18
SI1275647T1 (en) 2004-02-29
FR2827288A1 (fr) 2003-01-17
DE60200089T2 (de) 2004-09-09
HK1050682A1 (en) 2003-07-04
CA2394027A1 (fr) 2003-01-12
MXPA02006699A (es) 2005-08-16
AU2002300094B2 (en) 2007-06-14
NO20023345L (no) 2003-01-13
FR2827288B1 (fr) 2003-10-31
HU0202282D0 (enExample) 2002-09-28
CA2394027C (fr) 2008-01-08
US6992085B2 (en) 2006-01-31
NZ520120A (en) 2004-03-26
EA005160B1 (ru) 2004-12-30
KR100485020B1 (ko) 2005-04-25
ATE254124T1 (de) 2003-11-15
NO20023345D0 (no) 2002-07-11
HUP0202282A2 (hu) 2003-03-28
NO322966B1 (no) 2006-12-18
BR0202681A (pt) 2003-05-06
JP3950018B2 (ja) 2007-07-25
CN1197863C (zh) 2005-04-20
ZA200205596B (en) 2003-03-27
EA200200663A1 (ru) 2003-02-27
HUP0202282A3 (en) 2003-11-28
DK1275647T3 (da) 2004-03-15
KR20030007159A (ko) 2003-01-23
PL355034A1 (en) 2003-01-13
EP1275647B1 (fr) 2003-11-12
JP2003064081A (ja) 2003-03-05

Similar Documents

Publication Publication Date Title
WO2003087094A3 (en) Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors
BR0016396A (pt) Novos antagonistas do receptor p2x7 para uso no tratamento de doenças inflamatórias, imunes ou cardiovasculares
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
IL123293A (en) Piperidine derivatives, their preparation and pharmaceutical compositions containing them
NO20015379D0 (no) Indolinderivater som progesteronantagonister
TR200102338T2 (tr) Siklik ikame edilmiş bağlı pirolokarbazoller ve izoindolonlar.
NO20026094D0 (no) Fusjonerte azepinderivater og deres anvendelse som antidiuretiske midler
PT1206473E (pt) Pirrolocarbazoles e isoindolonas fundidos isomericos
CY1110258T1 (el) Υποκατεστημενα παραγωγα c-κυκλοεξυλομεθυλαμινης
BRPI0415015A (pt) certas lactamas espirocìclicas substituìdas e uso destas como produtos farmacêuticos
SE9702773D0 (sv) Novel compounds
DE60220258D1 (de) Derivate von quinolyl-propyl-piperidine, deren herstellung und die sie enthaltenden zusamensetzungen
NO20035772L (no) Oksytocinagonister
EP1423137A4 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
WO2004112704A3 (en) Substituted piperidine compounds and methods of their use
MY134026A (en) ?-carboline derivatives and its pharmaceutical use against depression and anxiety
TR200200125T2 (tr) Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar.
CY1106376T1 (el) Δικυκλικα παραγωγα των αμινο-πυραζινονων, μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα πepιεχουν
EE200200252A (et) Antikehade kasutamine vaktsiinidena, antikehi sisaldavad farmatseutilised kompositsioonid, meetod antikehapreparaadi valmistamiseks ja meetod farmatseutilise kompositsiooni valmistamiseks
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
DE60112325D1 (de) Cyclisierungsverfahrensschritt bei der herstellung von chinolonen und naphthyridinen
MXPA02012015A (es) Ligandos de receptores para integrinas.
FR2827288B1 (fr) Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
BR0000850B1 (pt) mistura de 3-metiloct-6-enóis 6-substituìdos, composição adorante contendo a referida mistura, bem como seu uso.